These data suggest that HER2 endows lung fibroblasts with a metastatic lung cancer–related signature program, which potentially defines HER2 as the master regulator of IPF lung fibroblast invasion and subsequently lung fibrosis. Here, ERBB2 is linked to idiopathic pulmonary fibrosis.